Scholar Rock Holding Corp
For the period ended Dec 31, 2023. Filed Mar 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 19, 2024
SRRK$48.00-6.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Year Ended | ||||||
| · · December 31, | ||||||
| · 2023 · 2022 | ||||||
| Cash flows from operating activities: · · · · | ||||||
| Net loss | | $(165,789) | | $(134,502) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | ||
| Depreciation and amortization | | 2,844 | | 2,986 | ||
| Amortization of debt discount and debt issuance costs | | | 274 | | | 720 |
| Loss on disposal of property and equipment | | | 11 | | | 33 |
| Equity-based compensation | | 27,142 | | 27,701 | ||
| Amortization/accretion of investment securities | | | (6,220) | | | (2,142) |
| Non-cash operating lease expense | | | 7,126 | | | 6,899 |
| Change in operating assets and liabilities: | | | | | ||
| Prepaid expenses and other current assets | | 4,530 | | (322) | ||
| Other assets | | | (2,698) | | | (97) |
| Accounts payable | | (529) | | (251) | ||
| Accrued expenses | | (3,927) | | 6,889 | ||
| Operating lease liabilities | | | (7,852) | | | (7,407) |
| Deferred revenue | | | — | | | (33,193) |
| Other liabilities | | | (138) | | | (8) |
| Net cash used in operating activities | | (145,226) | | | (132,694) | |
| Cash flows from investing activities: | | | | | ||
| Purchases of property and equipment | | (71) | | | (1,064) | |
| Proceeds from sale of property and equipment | | | 13 | | | — |
| Purchases of marketable securities | | | (290,801) | | | (300,634) |
| Maturities of marketable securities | | 332,000 | | | 130,000 | |
| Net cash provided by (used in) investing activities | | 41,141 | | (171,698) | ||
| Cash flows from financing activities: | | | | | ||
| Proceeds from sale of common shares, pre-funded warrants and warrants to purchase common shares, net of issuance costs | | | 97,709 | | | 195,315 |
| Proceeds from pre-funded and common warrant exercises | | | 3,463 | | | — |
| Proceeds from stock option exercises | | | 1,399 | | | 492 |
| Other | | | 3 | | | — |
| Debt modification payment | | | — | | | (975) |
| Net cash provided by financing activities | | 102,574 | | 194,832 | ||
| Net decrease in cash, cash equivalents and restricted cash | | (1,511) | | (109,560) | ||
| Cash, cash equivalents and restricted cash, beginning of period | | 105,773 | | | 215,333 | |
| Cash, cash equivalents and restricted cash, end of period | | $104,262 | | $105,773 | ||
| Supplemental cash flow information: | | | | | ||
| Cash paid for interest | | $6,399 | | $4,372 | ||
The accompanying notes are an integral part of these consolidated financial statements**.**
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.